시장보고서

상품코드

2016034

아페레시스 시장 보고서 : 컴포넌트별, 제품별, 기술별, 시술별, 용도별, 최종사용자별, 지역별(2026-2034년)

Apheresis Market Report by Component (Plasma, Platelets, Leukocytes, Lymphocytes, RBCs ), Product, Technology, Procedure, Application, End User, and Region 2026-2034

발행일: 2026년 04월 | 리서치사: 구분자

IMARC | 페이지 정보: 영문 147 Pages | 배송안내 : 2-3일 (영업일 기준)

가격

PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트 등의 Copy&Paste도 불가능합니다.

US $ 3,999

￦ 5,886,000

PDF & Excel (5 User License)

PDF & Excel 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy&Paste가 불가능합니다. 인쇄는 5부까지 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,999

￦ 7,359,000

PDF & Excel (Corporate License)

PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy&Paste가 가능합니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,999

￦ 8,831,000

※ 부가세 별도

한글목차

영문목차

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 아페레시스 시장 규모는 2025년에 33억 달러에 이르렀습니다. 향후, IMARC Group은 2034년까지 시장 규모가 57억 달러에 이르고, 2026-2034년 CAGR 6.01%를 나타낼 것으로 예측했습니다.

아페레시스(Apheresis)는 적혈구(RBC), 백혈구(WBC), 혈소판, 혈장 등의 헌혈 성분을 분리하여 다양한 질환의 치료에 사용하는 시술입니다. 이는 적혈구(RBC)의 형태가 비정상적이어서 체내에 산소를 운반할 수 없는 겸상적혈구증 치료에 도움이 됩니다. 또한, 혈액을 농축시켜 장기 기능을 방해하는 비정상적인 백혈구(WBC)를 제거하는데도 사용됩니다. 또한, 중증 근무력증, 혈전성 혈소판 감소성 자반병(TTP) 등 혈액암과 혈액 질환의 치료에도 도움이 되기 때문에 전 세계 채혈센터, 병원, 외래진료센터에서 아페레시스가 널리 사용되고 있습니다.

아페레시스 시장 동향 :

자가면역성 용혈성 빈혈, 급성 산발성 뇌척수염, 신생아 심장 루푸스 등 다양한 질환을 치료하기 위한 아페레시스에 대한 수요 증가는 시장을 이끄는 주요 요인 중 하나입니다. 이와 더불어, 전 세계적으로 화상 및 외상 환자의 치료용 혈장 채취를 위한 아페레시스 활용이 증가하고 있습니다. 이는 급성장하는 의료 산업과 맞물려 시장 성장에 기여하고 있습니다. 또한, 중증 폐쇄성 동맥경화증을 치료하는 개량형 혈액 정화 장치를 도입하기 위한 연구개발(R&D) 활동에 대한 주요 시장 기업들의 투자가 증가하면서 시장에 긍정적인 영향을 미치고 있습니다. 또한, 원발성 면역결핍증과 혈우병 치료에 사용되는 원혈장에 대한 수요 증가는 업계 투자자들에게 매력적인 성장 기회를 제공합니다. 이 외에도 혈전성 혈소판감소성 자반병, 용혈성 요독 증후군, 약물중독, 자가면역질환, 패혈증, 극증성 간부전 등 다양한 질환의 치료제로 아펠라시스가 점점 더 많이 활용되고 있다는 점이 시장 전망을 밝게 하고 있습니다. 또한, 아펠라시스의 장점에 대한 대중의 인식이 높아지면서 시장 성장에 힘을 실어주고 있습니다.

Apheresis is a procedure of separating donated blood components, such as red blood cells (RBCs), white blood cells (WBCs), platelets, and plasma, to treat various diseases. It assists in treating sickle cell disease wherein red blood cells (RBCs) are shaped abnormally and cannot carry oxygen through the body. It is also employed to remove abnormal white blood cells (WBCs) that thicken the blood and interfere with organ function. In addition, as it aids in treating blood cancers and blood disorders, such as myasthenia gravis and thrombotic thrombocytopenic purpura (TTP), apheresis is widely used in blood collection centers, hospitals, and ambulatory centers across the globe.

APHERESIS MARKET TRENDS:

The growing demand for apheresis to treat various diseases, such as autoimmune hemolytic anemia, acute disseminated encephalomyelitis, and cardiac neonatal lupus, represents one of the key factors driving the market. Besides this, there is a rise in the utilization of apheresis to collect plasma for treating burnt and trauma patients across the globe. This, along with the burgeoning healthcare industry, is contributing to the growth of the market. Moreover, increasing investments by key market players in research and development (R&D) activities to introduce an enhanced blood purification device that treats severe forms of arteriosclerosis obliterans is positively influencing the market. In addition, the rising demand for source plasma to treat primary immunodeficiency and hemophilia is offering lucrative growth opportunities to industry investors. Apart from this, the growing employment of apheresis as a therapy for various diseases, such as thrombotic thrombocytopenic purpura, hemolytic uremic syndrome , drug toxicities, autoimmune disease, sepsis, and fulminant hepatic failure, is offering a positive market outlook. Additionally, the increasing awareness among the masses about the benefits of apheresis is bolstering the growth of the market.

KEY MARKET SEGMENTATION:

Breakup by Component:

Plasma (Plasmapheresis)
Platelets (Plateletpheresis)
Leukocytes (Leukapheresis or Leukopheresis)
Lymphocytes (Lymphopheresis or Lymphapheresis)
RBC's (Erythropheresis)

Breakup by Product:

Devices
Disposables and Reagents
Software

Breakup by Technology:

Centrifugation
Membrane Separation
Selective Adsorption

Breakup by Procedure:

Donor/Automated Apheresis
Therapeutic Apheresis

Breakup by Application:

Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Others

Breakup by End User:

Blood Centers
Hospitals
Others

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

COMPETITIVE LANDSCAPE:

The report provides a comprehensive analysis of the competitive landscape in the global apheresis market with detailed profiles of all major companies, including:

Asahi Kasei Medical Co. Ltd.
B. Braun SE
Fresenius Kabi AG
Haemonetics Corporation
Haier Biomedical
Infomed SA
Kaneka Medical Europe N.V.
Medica SPA
Miltenyi Biotec
SB-Kawasumi Laboratories, Inc.
Terumo BCT, Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global apheresis market in 2025?

2. What is the expected growth rate of the global apheresis market during 2026-2034?

3. What are the key factors driving the global apheresis market?

4. What has been the impact of COVID-19 on the global apheresis market?

5. What is the breakup of the global apheresis market based on the component?

6. What is the breakup of the global apheresis market based on the product?

7. What is the breakup of the global apheresis market based on the technology?

8. What is the breakup of the global apheresis market based on procedure?

9. What is the breakup of the global apheresis market based on the application?

10. What is the breakup of the global apheresis market based on the end user?

11. What are the key regions in the global apheresis market?

12. Who are the key players/companies in the global apheresis market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Apheresis Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Component

6.1 Plasma (Plasmapheresis)
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Platelets (Plateletpheresis)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Leukocytes (Leukapheresis or Leukopheresis)
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Lymphocytes (Lymphopheresis or Lymphapheresis)
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 RBC's (Erythropheresis)
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Product

7.1 Devices
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Disposables and Reagents
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Software
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Technology

8.1 Centrifugation
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Membrane Separation
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Selective Adsorption
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Procedure

9.1 Donor/Automated Apheresis
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Therapeutic Apheresis
- 9.2.1 Market Trends
- 9.2.2 Market Forecast

10 Market Breakup by Application

10.1 Renal Disorders
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Hematological Disorders
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Neurological Disorders
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
10.4 Autoimmune Disorders
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
10.5 Others
- 10.5.1 Market Trends
- 10.5.2 Market Forecast

11 Market Breakup by End User

11.1 Blood Centers
- 11.1.1 Market Trends
- 11.1.2 Market Forecast
11.2 Hospitals
- 11.2.1 Market Trends
- 11.2.2 Market Forecast
11.3 Others
- 11.3.1 Market Trends
- 11.3.2 Market Forecast

12 Market Breakup by Region

12.1 North America
- 12.1.1 United States
  - 12.1.1.1 Market Trends
  - 12.1.1.2 Market Forecast
- 12.1.2 Canada
  - 12.1.2.1 Market Trends
  - 12.1.2.2 Market Forecast
12.2 Asia-Pacific
- 12.2.1 China
  - 12.2.1.1 Market Trends
  - 12.2.1.2 Market Forecast
- 12.2.2 Japan
  - 12.2.2.1 Market Trends
  - 12.2.2.2 Market Forecast
- 12.2.3 India
  - 12.2.3.1 Market Trends
  - 12.2.3.2 Market Forecast
- 12.2.4 South Korea
  - 12.2.4.1 Market Trends
  - 12.2.4.2 Market Forecast
- 12.2.5 Australia
  - 12.2.5.1 Market Trends
  - 12.2.5.2 Market Forecast
- 12.2.6 Indonesia
  - 12.2.6.1 Market Trends
  - 12.2.6.2 Market Forecast
- 12.2.7 Others
  - 12.2.7.1 Market Trends
  - 12.2.7.2 Market Forecast
12.3 Europe
- 12.3.1 Germany
  - 12.3.1.1 Market Trends
  - 12.3.1.2 Market Forecast
- 12.3.2 France
  - 12.3.2.1 Market Trends
  - 12.3.2.2 Market Forecast
- 12.3.3 United Kingdom
  - 12.3.3.1 Market Trends
  - 12.3.3.2 Market Forecast
- 12.3.4 Italy
  - 12.3.4.1 Market Trends
  - 12.3.4.2 Market Forecast
- 12.3.5 Spain
  - 12.3.5.1 Market Trends
  - 12.3.5.2 Market Forecast
- 12.3.6 Russia
  - 12.3.6.1 Market Trends
  - 12.3.6.2 Market Forecast
- 12.3.7 Others
  - 12.3.7.1 Market Trends
  - 12.3.7.2 Market Forecast
12.4 Latin America
- 12.4.1 Brazil
  - 12.4.1.1 Market Trends
  - 12.4.1.2 Market Forecast
- 12.4.2 Mexico
  - 12.4.2.1 Market Trends
  - 12.4.2.2 Market Forecast
- 12.4.3 Others
  - 12.4.3.1 Market Trends
  - 12.4.3.2 Market Forecast
12.5 Middle East and Africa
- 12.5.1 Market Trends
- 12.5.2 Market Breakup by Country
- 12.5.3 Market Forecast

13 SWOT Analysis

13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
- 17.3.1 Asahi Kasei Medical Co. Ltd.
  - 17.3.1.1 Company Overview
  - 17.3.1.2 Product Portfolio
- 17.3.2 B. Braun SE
  - 17.3.2.1 Company Overview
  - 17.3.2.2 Product Portfolio
  - 17.3.2.3 SWOT Analysis
- 17.3.3 Fresenius Kabi AG
  - 17.3.3.1 Company Overview
  - 17.3.3.2 Product Portfolio
  - 17.3.3.3 Financials
  - 17.3.3.4 SWOT Analysis
- 17.3.4 Haemonetics Corporation
  - 17.3.4.1 Company Overview
  - 17.3.4.2 Product Portfolio
  - 17.3.4.3 Financials
  - 17.3.4.4 SWOT Analysis
- 17.3.5 Haier Biomedical
  - 17.3.5.1 Company Overview
  - 17.3.5.2 Product Portfolio
- 17.3.6 Infomed SA
  - 17.3.6.1 Company Overview
  - 17.3.6.2 Product Portfolio
  - 17.3.6.3 Financials
  - 17.3.6.4 SWOT Analysis
- 17.3.7 Kaneka Medical Europe N.V.
  - 17.3.7.1 Company Overview
  - 17.3.7.2 Product Portfolio
  - 17.3.7.3 Financials
  - 17.3.7.4 SWOT Analysis
- 17.3.8 Medica SPA
  - 17.3.8.1 Company Overview
  - 17.3.8.2 Product Portfolio
  - 17.3.8.3 Financials
- 17.3.9 Miltenyi Biotec
  - 17.3.9.1 Company Overview
  - 17.3.9.2 Product Portfolio
- 17.3.10 SB-Kawasumi Laboratories, Inc.
  - 17.3.10.1 Company Overview
  - 17.3.10.2 Product Portfolio
- 17.3.11 Terumo BCT, Inc.
  - 17.3.11.1 Company Overview
  - 17.3.11.2 Product Portfolio

아페레시스 시장 보고서 : 컴포넌트별, 제품별, 기술별, 시술별, 용도별, 최종사용자별, 지역별(2026-2034년)

Apheresis Market Report by Component (Plasma, Platelets, Leukocytes, Lymphocytes, RBCs ), Product, Technology, Procedure, Application, End User, and Region 2026-2034

아페레시스 시장 동향 :

목차

제1장 서문

제2장 조사 범위와 조사 방법

제3장 주요 요약

제4장 서론

제5장 세계의 아페레시스 시장

제6장 시장 분석 : 컴포넌트별

제7장 시장 분석 : 제품별

제8장 시장 분석 : 기술별

제9장 시장 분석 : 시술별

제10장 시장 분석 : 용도별

제11장 시장 분석 : 최종사용자별

제12장 시장 분석 : 지역별

제13장 SWOT 분석

제14장 밸류체인 분석

제15장 Porter의 Five Forces 분석

제16장 가격 분석

제17장 경쟁 구도